☆ 4.3 Article

The Efficacy of Radiotherapy in the Treatment of Hepatocellular Carcinoma with Distant Organ Metastasis

JOURNAL OF ONCOLOGY (2021)

Related references

Note: Only part of the references are listed.

Article Oncology

External Beam Radiation Therapy for Liver Metastases

Paul B. Romesser et al.

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Add to Collection

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Add to Collection

Article Oncology

Electron beam intraoperative radiotherapy for metastatic epidural spinal cord compression: a prospective observational study

Kei Ito et al.

Summary: The study demonstrates that decompression surgery and IORT followed by EBRT are effective in achieving local control and maintaining ambulation in patients with MESCC.

CLINICAL & EXPERIMENTAL METASTASIS (2021)

Add to Collection

Article Oncology

Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma

Tae Hyung Kim et al.

Summary: Ablative radiotherapy has shown significant improvement in overall survival and pain palliation in patients with bone metastasis from hepatocellular carcinoma. Results indicate a median overall survival of 5.1 months after ablative radiotherapy, with patients with oligometastasis showing longer survival compared to those without metastases.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Add to Collection

Review Oncology

Radiotherapy of oligometastatic prostate cancer: a systematic review

Paul Rogowski et al.

Summary: This review summarizes the current evidence on radiation therapy as metastasis-directed therapy for oligometastatic prostate cancer, showing high local control rates and a proportion of patients without progressive disease after 2 years. Ongoing research is focusing on identifying relevant prognostic and predictive factors.

RADIATION ONCOLOGY (2021)

Add to Collection

Review Oncology

Radiotherapy for locally advanced pancreatic ductal adenocarcinoma

Elizabeth J. Buss et al.

Summary: This review summarizes the expanding role of radiotherapy in the management of locally advanced, unresectable pancreatic cancer. Higher, ablative doses of radiation and advancements in technology have been shown to improve patient survival rates.

SEMINARS IN ONCOLOGY (2021)

Add to Collection

Review Oncology

MR-Guided Adaptive Radiotherapy for Bladder Cancer

Adham Hijab et al.

Summary: Radiotherapy plays a significant role in both curative and palliative treatment of bladder cancer, but faces technical challenges such as poor tumor visualization and bladder size variability. Magnetic resonance imaging (MRI) is favored for tumor visualization and staging, and the integration of MRI scanning with linear accelerator in MR-Linac systems allows for real-time plan adaptation during treatment, potentially improving outcomes for bladder cancer patients. However, robust evidence is needed to determine if MR-guided radiotherapy translates into better patient outcomes before widespread clinical implementation.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Breast cancer

Sibylle Loibl et al.

Summary: Breast cancer diagnosis and treatment have become increasingly complex, incorporating various biomarkers and neoadjuvant therapies, with de-escalation schemes for radiotherapy now becoming standard practice.

LANCET (2021)

Add to Collection

Review Medicine, General & Internal

Advanced Techniques in the Percutaneous Ablation of Liver Tumours

Terrence C. H. Hui et al.

Summary: Percutaneous ablation is a common treatment for liver tumors, with a focus on achieving necrosis of tumor cells while minimizing damage to surrounding tissue. Considerations include choosing appropriate imaging and protective techniques to optimize outcomes and achieve satisfactory ablation margins.

DIAGNOSTICS (2021)

Add to Collection

Review Gastroenterology & Hepatology

Experience with regorafenib in the treatment of hepatocellular carcinoma

Alessandro Granito et al.

Summary: Regorafenib, structurally similar to sorafenib, shows significant survival advantage in unresectable hepatocellular carcinoma (HCC) patients who failed first-line treatment, by targeting angiogenic and tumor growth-promoting pathways, inhibiting tumor neo-angiogenesis and proliferation, and modulating the tumor microenvironment. It is being explored for use in combination therapy with immune checkpoint blockade and for extended use in patient categories beyond registrative studies.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Outcome of Radiation Therapy for Stage IVB Uterine Cervical Cancer With Distant Lymph Nodes Metastases; Sequential Irradiation for Distant Lymph Nodes Metastases

Yuki Mukai et al.

Summary: This study showed that radiation therapy had favorable local control in patients with distant LN metastases from uterine cervical cancer. Additionally, there were improvements in survival rates and disease progression among these patients.

IN VIVO (2021)

Add to Collection

Review Gastroenterology & Hepatology

Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation

Paul J. Thuluvath et al.

Summary: Hepatocellular cancer is a common and deadly cancer worldwide. Liver transplantation is the preferred treatment for unresectable HCC, but due to long waiting periods, locoregional therapies may be needed for some patients.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Oncology

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer The ORIOLE Phase 2 Randomized Clinical Trial

Ryan Phillips et al.

JAMA ONCOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis

Ian Poon et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Article Oncology

Efficacy and safety of drug-eluting bead-transcatheter arterial chemoembolization using 100-300 μm versus 300-500 μm CalliSpheres microspheres in patients with advanced-stage hepatocellular carcinoma

Tiangu Yang et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2020)

Add to Collection

Article Oncology

Impact of Extrahepatic Metastases on Overall Survival in Patients with Advanced Liver Dominant Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial

Kerstin Schuette et al.

LIVER CANCER (2020)

Add to Collection

Review Gastroenterology & Hepatology

Surgical Resection Old Dog, Any New Tricks?

Yoshikuni Kawaguchi et al.

CLINICS IN LIVER DISEASE (2020)

Add to Collection

Article Oncology

125I seed implantation for hepatocellular carcinoma with portal vein tumor thrombus: A systematic review and meta-analysis

Deyue Yuan et al.

BRACHYTHERAPY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

Jens Ricke et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Article Oncology

Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial

Juxian Sun et al.

RADIOTHERAPY AND ONCOLOGY (2019)

Add to Collection

Article Oncology

Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis

Junqing Lin et al.

BRACHYTHERAPY (2019)

Add to Collection

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection

Review Pharmacology & Pharmacy

An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib

L. Ielasi et al.

DRUGS OF TODAY (2018)

Add to Collection

Article Gastroenterology & Hepatology

The evolutionary scenario of hepatocellular carcinoma in Italy: an update

Laura Bucci et al.

LIVER INTERNATIONAL (2017)

Add to Collection

Review Oncology

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

J. -L. Raoul et al.

CANCER TREATMENT REVIEWS (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.